Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 2 |
2021 | 2 |
2022 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
ALK-Brain Prognostic Index-Preliminary Study of a Prognostic Tool for Patients with ALK-Rearranged, Non-small Cell Lung Cancer and Brain Metastases.
Cancers (Basel). 2020 Jul 6;12(7):1804. doi: 10.3390/cancers12071804.
Cancers (Basel). 2020.
PMID: 32640547
Free PMC article.
Ras-Related Protein Rab-32 and Thrombospondin 1 Confer Resistance to the EGFR Tyrosine Kinase Inhibitor Osimertinib by Activating Focal Adhesion Kinase in Non-Small Cell Lung Cancer.
Kosibaty Z, Brustugun OT, Zwicky Eide IJ, Tsakonas G, Grundberg O, De Petris L, McGowan M, Hydbring P, Ekman S.
Kosibaty Z, et al.
Cancers (Basel). 2022 Jul 14;14(14):3430. doi: 10.3390/cancers14143430.
Cancers (Basel). 2022.
PMID: 35884490
Free PMC article.
Item in Clipboard
High Density of NRF2 Expression in Malignant Cells Is Associated with Increased Risk of CNS Metastasis in Early-Stage NSCLC.
Tsakonas G, Martín-Bernabé A, Rounis K, Moreno-Ruiz P, Botling J, De Petris L, Ylipää A, Mezheyeuski A, Micke P, Östman A, Ekman S.
Tsakonas G, et al.
Cancers (Basel). 2021 Jun 24;13(13):3151. doi: 10.3390/cancers13133151.
Cancers (Basel). 2021.
PMID: 34202448
Free PMC article.
Item in Clipboard
Outcome of Patients with NSCLC and Brain Metastases Treated with Immune Checkpoint Inhibitors in a 'Real-Life' Setting.
Skribek M, Rounis K, Makrakis D, Agelaki S, Mavroudis D, De Petris L, Ekman S, Tsakonas G.
Skribek M, et al.
Cancers (Basel). 2020 Dec 10;12(12):3707. doi: 10.3390/cancers12123707.
Cancers (Basel). 2020.
PMID: 33321730
Free PMC article.
Item in Clipboard
Correlation of Clinical Parameters with Intracranial Outcome in Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Pd-1/Pd-L1 Inhibitors as Monotherapy.
Rounis K, Skribek M, Makrakis D, De Petris L, Agelaki S, Ekman S, Tsakonas G.
Rounis K, et al.
Cancers (Basel). 2021 Mar 29;13(7):1562. doi: 10.3390/cancers13071562.
Cancers (Basel). 2021.
PMID: 33805335
Free PMC article.
Item in Clipboard
Cite
Cite